Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Joseph Mocanu

Principal, Health & Life Sciences, Oliver Wyman

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Oliver Wyman’s Health & Life Sciences Singapore-based team, led by Jeremy Lim, offers the following dispatch from the Asia Pacific Rim. They explain why it’s up to enterprising industry players and disrupters from the private sector to initiate new ways of providing and financing care to reach the masses in these huge, relatively unexplored markets:

Head of Health & Life Sciences, Asia-Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman